Virological breakthrough in chronic HBV Egyptian patients receiving lamivudine therapy / Kamal Hassan Kamal ; Supervised Gamal Eldin Esmat , Hanan Abdelhafez , Soheir Ismail

By:

Kamal Hassan Kamal

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Kamal Hassan Kamal , 2012Description: 123P. : charts ; 25cmOther title:

المقاومة الفيروسية لعقار اللاميفيدين فى المرضى المصريين المصابين بالإلتهاب الكبدى القيروسى (ب) المزمن [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine Summary: The goal of therapy for hepatitis B is suppression of HBV replication in a sustained manner thus preventing further progression of the disease . In HBeAg- negative chronic hepatitis B (CHB) lamivudine is reported to be highly effective in suppressing serum HBV- DNA to undetectable levels by PCR assays but selection of lamivudine resistant mutants in the main concern

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.33.M.Sc.2012.Ka.V (Browse shelf(Opens below))		Not for loan	01010110059509000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.33.M.Sc.2012.Ka.V (Browse shelf(Opens below))	59509.CD	Not for loan	01020110059509000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.33.M.Sc.2012.Ha.T Tuberculosis as a re-emerging disease /	Cai01.11.33.M.Sc.2012.Ha.T Tuberculosis as a re-emerging disease /	Cai01.11.33.M.Sc.2012.Ka.V Virological breakthrough in chronic HBV Egyptian patients receiving lamivudine therapy /	Cai01.11.33.M.Sc.2012.Ka.V Virological breakthrough in chronic HBV Egyptian patients receiving lamivudine therapy /	Cai01.11.33.M.Sc.2012.Ma.H HIV prevalence among HCV infected patients and its impact on the result of HCV treatment /	Cai01.11.33.M.Sc.2012.Ma.H HIV prevalence among HCV infected patients and its impact on the result of HCV treatment /	Cai01.11.33.M.Sc.2012.Mo.A Acid - base disturbance in patients with hepatic encephalopathy /	Next

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine

The goal of therapy for hepatitis B is suppression of HBV replication in a sustained manner thus preventing further progression of the disease . In HBeAg- negative chronic hepatitis B (CHB) lamivudine is reported to be highly effective in suppressing serum HBV- DNA to undetectable levels by PCR assays but selection of lamivudine resistant mutants in the main concern

Issued also as CD

There are no comments on this title.

to post a comment.